Y Kan

3.6k total citations · 2 hit papers
33 papers, 3.0k citations indexed

About

Y Kan is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Y Kan has authored 33 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Genetics and 9 papers in Hematology. Recurrent topics in Y Kan's work include Hemoglobinopathies and Related Disorders (15 papers), RNA modifications and cancer (6 papers) and Iron Metabolism and Disorders (4 papers). Y Kan is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), RNA modifications and cancer (6 papers) and Iron Metabolism and Disorders (4 papers). Y Kan collaborates with scholars based in United States, China and Italy. Y Kan's co-authors include A M Dozy, Judy C. Chang, E. A. Zimmer, Sandra L. Martin, Allan C. Wilson, Stephen M. Beverley, Stephen H. Embury, SA Liebhaber, Paolo Moi and R V Lebo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Y Kan

31 papers receiving 2.7k citations

Hit Papers

Polymorphism of DNA sequence adjacent to human beta-globi... 1978 2026 1994 2010 1978 1980 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Kan United States 23 1.5k 1.1k 742 597 246 33 3.0k
Juan J. Yunis United States 38 1.5k 1.0× 483 0.5× 868 1.2× 1.3k 2.2× 379 1.5× 173 4.8k
H H Kazazian United States 32 1.7k 1.1× 1.1k 1.0× 1.1k 1.5× 857 1.4× 195 0.8× 64 3.2k
Andrea Angius Italy 31 942 0.6× 305 0.3× 444 0.6× 569 1.0× 158 0.6× 100 2.5k
Park S. Gerald United States 34 1.8k 1.2× 575 0.5× 473 0.6× 1.2k 1.9× 352 1.4× 111 3.6k
Mario Pirastu Italy 36 878 0.6× 1.4k 1.4× 1.3k 1.8× 801 1.3× 136 0.6× 135 3.5k
Corinne D. Boehm United States 22 1.4k 0.9× 1.6k 1.5× 1.1k 1.5× 812 1.4× 223 0.9× 38 3.3k
Kay L. Medina United States 34 1.9k 1.3× 361 0.3× 848 1.1× 546 0.9× 105 0.4× 72 5.1k
Giandomenico Palka Italy 31 1.5k 1.0× 376 0.4× 395 0.5× 1.5k 2.5× 284 1.2× 145 3.3k
Thomas E. Curry United States 36 924 0.6× 314 0.3× 498 0.7× 769 1.3× 60 0.2× 135 4.1k
Patrick Nitschké France 33 1.9k 1.3× 202 0.2× 348 0.5× 1.0k 1.7× 56 0.2× 78 3.7k

Countries citing papers authored by Y Kan

Since Specialization
Citations

This map shows the geographic impact of Y Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Kan more than expected).

Fields of papers citing papers by Y Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Kan. The network helps show where Y Kan may publish in the future.

Co-authorship network of co-authors of Y Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Y Kan. A scholar is included among the top collaborators of Y Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Kan. Y Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kan, Y, et al.. (2025). Meta-analysis of long non-coding RNA expression profile in Parkinson’s disease. Brain Research. 1863. 149838–149838.
4.
Jin, Hengwei, et al.. (2014). Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis.. PubMed. 58(1). 85–93. 31 indexed citations
5.
Ma, Chuang, Lihong Chen, Y Kan, et al.. (2012). Evaluation of the Clinical Features of Hepatocellular Carcinoma following Hepatectomy for Different Stages of Hepatocellular Carcinoma. Hepatogastroenterology. 11 indexed citations
6.
Su, Hua, Yerem Yeghiazarians, Yu-Wen Huang, et al.. (2007). AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid. The Journal of Gene Medicine. 10(1). 33–41. 20 indexed citations
7.
Rogers, Rachel, Túlio M. Graziottin, Chang‐Shen Lin, Y Kan, & Tom F. Lue. (2003). Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. International Journal of Impotence Research. 15(1). 26–37. 150 indexed citations
8.
Bakırcıoğlu, Emre, Ching‐Shwun Lin, Peng‐Dong Fan, et al.. (2001). THE EFFECT OF ADENO-ASSOCIATED VIRUS MEDIATED BRAIN DERIVED NEUROTROPHIC FACTOR IN AN ANIMAL MODEL OF NEUROGENIC IMPOTENCE. The Journal of Urology. 2103–2109. 28 indexed citations
9.
Hu, Lily, et al.. (2001). A Hypoxia-Regulated Adeno-Associated Virus Vector for Cancer-Specific Gene Therapy. Neoplasia. 3(3). 255–263. 76 indexed citations
10.
Chan, Julia Y., Xiaosong Han, & Y Kan. (1993). Isolation of cDNA encoding the human NF-E2 protein.. Proceedings of the National Academy of Sciences. 90(23). 11366–11370. 109 indexed citations
11.
Cai, Shi‐Ping & Y Kan. (1990). Identification of the multiple beta-thalassemia mutations by denaturing gradient gel electrophoresis.. Journal of Clinical Investigation. 85(2). 550–553. 66 indexed citations
12.
Moi, Paolo & Y Kan. (1990). Synergistic enhancement of globin gene expression by activator protein-1-like proteins.. Proceedings of the National Academy of Sciences. 87(22). 9000–9004. 94 indexed citations
13.
Dunbar, Cynthia E., William D. Travis, Y Kan, & Arthur W. Nienhuis. (1989). 5‐AZACYTIDINE TREATMENT IN A βo‐THALASSAEMIC PATIENT UNABLE TO BE TRANSFUSED DUE TO MULTIPLE ALLOANTIBODIES. British Journal of Haematology. 72(3). 467–467. 21 indexed citations
14.
Law, M L, et al.. (1988). Type of β-Thalassemia Mutations Found in the Chinese Identified by Synthetic Oligonucleotides. Hemoglobin. 12(5-6). 577–577. 1 indexed citations
15.
Pirastu, Mario, Giuseppe Saglio, Judy C. Chang, Aili Cao, & Y Kan. (1984). Initiation codon mutation as a cause of alpha thalassemia.. Journal of Biological Chemistry. 259(20). 12315–12317. 116 indexed citations
16.
Chang, Judy C. & Y Kan. (1982). A sensitive test for prenatal diagnosis of sickle cell anemia: direct analysis of amniocyte DNA with MstII.. PubMed. 95. 71–8. 6 indexed citations
17.
Goossens, M., et al.. (1980). Triplicated alpha-globin loci in humans.. Proceedings of the National Academy of Sciences. 77(1). 518–521. 205 indexed citations
18.
Zimmer, E. A., Sandra L. Martin, Stephen M. Beverley, Y Kan, & Allan C. Wilson. (1980). Rapid duplication and loss of genes coding for the alpha chains of hemoglobin.. Proceedings of the National Academy of Sciences. 77(4). 2158–2162. 449 indexed citations breakdown →
19.
Temple, Gary F., Judy C. Chang, & Y Kan. (1977). Authentic beta-globin mRNA sequences in homozygous betaO-thalassemia.. Proceedings of the National Academy of Sciences. 74(7). 3047–3051. 58 indexed citations
20.
Kan, Y, A. J. S. McFadzean, D. Todd, & S. C. Tso. (1961). Further Observations on Polycythemia in Hepatocellular Carcinoma. Blood. 18(5). 592–598. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026